Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy
Renée E. Poupon, Yves Chrétien, Raoul Poupon, Gustav Paumgartner – 1 April 1993 – Serum bile acid levels and distributions were studied every 6 mo in patients with primary biliary cirrhosis who were randomly assigned to receive ursodeoxycholic acid (13 to 15 mg/kg/day) (n = 73) or a placebo (n = 73) over a 2‐yr period. In the ursodeoxycholic acid group, ursodeoxycholic acid was the predominant serum bile acid at 6 mo and throughout the 2‐yr treatment period.